Vancomycin in the Target Site Treatment of Intracranial Infection
NCT03585426
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Vancomycin
Interventions
DRUG:
Vancomycin
Sponsor
Xijing Hospital